MIB1
protein-codingMIB E3 ubiquitin protein ligase 1, the group of Zinc fingers ZZ-type|Ankyrin repeat domain containing|MicroRNA protein coding host genes|Ring finger proteins
Gene summary
This gene encodes a protein containing multiple ankyrin repeats and RING finger domains that functions as an E3 ubiquitin ligase. The encoded protein positively regulates Notch signaling by ubiquitinating the Notch receptors, thereby facilitating their endocytosis. This protein may also promote the ubiquitination and degradation of death-associated protein kinase 1 (DAPK1). [provided by RefSeq, Jun 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~166.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0018901
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0005021
Submitter: ClinGen
MIB1 was originally evaluated for DCM by the ClinGen DCM GCEP on November 8, 2019. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on October 4, 2024. As a result, the classification changed from no known disease relationship to limited. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. MIB1 was first reported in relation to autosomal dominant dilated cardiomyopathy in 2013 (Luxan et al. PMID: 23314057). Human genetic evidence supporting this gene-disease relationship includes case-level data. Four variants (2 missense, 1 splice site, 1 truncating) have been reported in humans in 2 studies (Luxan et al. PMID 23314057, Hazebroek et al. PMID: 29540472). Segregation was demonstrated in 2 families in Luxan et al. although, interestingly, most affected relatives had isolated left ventricular hypertrabeculation, and it was only the probands from both families that had contractile dysfunction. Functional evidence was demonstrated for these 2 variants. Importantly, this paper did not exclude truncating TTN variants. Further, this gene appears to be tolerant of loss of function variants. Hazebroek et al. identified two MIB1 variants in people with non-dilated hypokinetic cardiomyopathy, without segregation or functional evidence. None of these variants were scored in the last curation due to insufficient DCM phenotype. While there have been no new publications demonstrating an association between MIB1 and DCM since the last curation, on re-evaluation of the genetic data, the 2024 working group thought the described phenotypes were reasonable and a small number of points were warranted for this genetic evidence. This gene disease association is supported by a mouse animal model (Luxan et al. PMID 23314057, Captur et al. PMID: 27020702), and expression studies (Luxan et al. PMID 23314057, Jin et al. PMID: 12351649). In summary, despite no new evidence, on re-curation of the genetic evidence for MIB1 and AD DCM, the expert panel have upgraded this gene-disease classification to Limited. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 4 October, 2024 (SOP Version 10).
Inheritance Pattern: Unknown
Disease ID:MONDO:0007336
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0014042
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014042
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: Left ventricular noncompaction may manifest as depressed systolic function, with potential complications including arrhythmias, systemic embolism, heart failure and sudden death, and surveillance (eg, with echocardiogram and electrocardiogram) may allow early diagnosis and treatment
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MIB1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020774.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 191 | 194 | |||
| missense | 2 | 309 | 5 | 316 | ||
| nonsense | 1 | 9 | 25 | 1 | 36 | |
| start loss | 0 | |||||
| frameshift | 16 | 31 | 47 | |||
| splice donor/acceptor (+/-2bp) | 5 | 11 | 16 | |||
| Total | 1 | 32 | 379 | 197 | 0 | 609 |
Highest pathogenic variant AF is 0.00010037644
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065825.1 | 21 | MANE Select | |
| Ensembl | ENSP00000261537.6 | 21 | MANE Select | |
| Ensembl | ENSP00000534071.1 | 20 | Standard | |
| Ensembl | ENSP00000534071.1 | 20 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| mib1 | Danio rerio | Structure: retinal ganglion cell Quality: dead abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- NOTCH-Ncore
- Disease
- Signal Transduction
- Signaling by NOTCH1
- Signaling by NOTCH2
Biological Process
- blood vessel development
- in utero embryonic development
- somitogenesis
- neural tube formation
- heart looping
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- zinc ion binding
Cellular Component
- cytoplasm
- centrosome
- cytosol
- plasma membrane
- postsynaptic density
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261537
- Coding exons
- 21
- Length
- 166001
- Individuals with no LoFs
- 125339
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 409
- Defined
- 125748
- p
- 0.00163
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.21 | 343 | 556 | 0.617 | 0.0000285 | 6612 |
| Missense (PolyPhen) | 87 | 167.28 | 0.5201 | 1899 | ||
| Synonymous | -0.413 | 199 | 192 | 1.04 | 0.00000949 | 1921 |
| Loss of Function | -5.81 | 105 | 57.5 | 1.83 | 0.00000350 | 615 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0017 | 0.0017 | notable |
| Latino/Admixed American | 0.0018 | 0.0018 | notable |
| Ashkenazi Jewish | 0.0019 | 0.0019 | notable |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0.0014 | 0.0014 | notable |
| European (Non-Finnish) | 0.0016 | 0.0016 | notable |
| South Asian | 0.0019 | 0.0019 | notable |
| Other | 0.0020 | 0.0020 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. Probably mediates ubiquitination and subsequent proteasomal degradation of DAPK1, thereby antagonizing anti-apoptotic effects of DAPK1 to promote TNF- induced apoptosis (By similarity). Involved in ubiquitination of centriolar satellite CEP131, CEP290 and PCM1 proteins and hence inhibits primary cilium formation in proliferating cells. Mediates 'Lys-63'-linked polyubiquitination of TBK1, which probably participates in kinase activation. {ECO:0000250, ECO:0000269|PubMed:24121310}.;
- Disease
- DISEASE: Left ventricular non-compaction 7 (LVNC7) [MIM:615092]: A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC7 is an autosomal dominant condition. {ECO:0000269|PubMed:23314057}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.290
Intolerance Scores
- LoFtool
- 0.882
- RVIS EVS
- -1.42
- RVIS percentile EVS
- 4.1
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.960
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |